Castle Biosciences CSTL Tax on Share Settlement
Tax on Share Settlement at other companies
Other financials
Where this comes from
Reported directly by Castle Biosciences in its filing.
Tagged under the XBRL concept us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation.
The official record: Castle Biosciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Castle Biosciences's tax on share settlement.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Castle Biosciences's tax on share settlement?
- Castle Biosciences (CSTL) reported tax on share settlement of $6.6M in Q1 2026.
- How has Castle Biosciences's tax on share settlement changed year-over-year?
- Castle Biosciences's tax on share settlement increased by 162.3% year-over-year, from $2.52M to $6.6M.
- What is the long-term trend for Castle Biosciences's tax on share settlement?
- Over 4 years (2021 to 2025), Castle Biosciences's tax on share settlement has grown at a 96.6% compound annual growth rate (CAGR), from $781K to $11.66M.
- What does tax on share settlement mean?
- Cash paid to tax authorities for employee share vesting, where the company withholds shares and pays the tax obligation in cash.